rs1800577
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000361.3(THBD):c.236G>C(p.Gly79Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000129 in 1,551,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000361.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152138Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000136 AC: 2AN: 146520Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 80218
GnomAD4 exome AF: 0.0000114 AC: 16AN: 1398858Hom.: 0 Cov.: 51 AF XY: 0.0000116 AC XY: 8AN XY: 690802
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74436
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 79 of the THBD protein (p.Gly79Ala). This variant is present in population databases (rs1800577, gnomAD 0.004%). This missense change has been observed in individual(s) with thromboembolic disease (PMID: 9198186). This variant is also known as Gly61Ala. ClinVar contains an entry for this variant (Variation ID: 809235). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt THBD protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Atypical hemolytic-uremic syndrome with thrombomodulin anomaly;C3280976:Thrombomodulin-related bleeding disorder Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at